Clinical impacts of frailty on 123,172 people with diabetes mellitus considering the age of onset and drugs of choice: a nationwide population-based 10-year trajectory analysis

Huang, Shih-TsungShih-TsungHuangChen, Liang-KungLiang-KungChenFEI-YUAN HSIAO2024-03-292024-03-292023-07-0100020729https://scholars.lib.ntu.edu.tw/handle/123456789/641656Frailty substantially increased the risk of adverse clinical outcomes, which was also critical in diabetes management. This study aimed to investigate the interrelationships between the age of onset, frailty, anti-diabetic medications and clinical outcomes in people with diabetes mellitus (DM).endiabetes mellitus; frailty; hypoglycaemia; major adverse cardiovascular events (MACEs); mortality; older people[SDGs]SDG2[SDGs]SDG3[SDGs]SDG5Clinical impacts of frailty on 123,172 people with diabetes mellitus considering the age of onset and drugs of choice: a nationwide population-based 10-year trajectory analysisjournal article10.1093/ageing/afad128375059892-s2.0-85168592099https://api.elsevier.com/content/abstract/scopus_id/85168592099